Literature DB >> 2712531

Development of dementing illnesses in an 80-year-old volunteer cohort.

R Katzman1, M Aronson, P Fuld, C Kawas, T Brown, H Morgenstern, W Frishman, L Gidez, H Eder, W L Ooi.   

Abstract

We have prospectively followed over a 5-year period 434 volunteers who were at intake ambulatory, functional, presumably nondemented, and between 75 and 85 years of age. Fifty-six (an incidence of 3.53 per 100 person-years at risk) developed a progressive dementia: 32 met diagnostic criteria for Alzheimer's disease (AD) (an incidence of 2.0 per 100 person-years at risk), 15 had vascular or mixed dementia, and 9 had other disorders or remain undiagnosed. New cases of dementia were as common as myocardial infarction and twice as common as stroke. Risk factors for both dementia and AD were age (over 80) and gender (female); other reported risk factors such as family history, prior head injury, thyroid disease, maternal age, and smoking were not risk factors for AD in this elderly cohort. Prior stroke was the major risk factor for vascular or mixed dementia; diabetes and left ventricular hypertrophy but not a history of hypertension per se were also risk factors for vascular dementia. The major predictor of the development of AD was the mental status score on entry. The 58.5% of the cohort who made zero to two errors on a 33-item mental status test had a less than 0.6% per year chance of developing AD, whereas the 16% of the cohort with five to eight errors on this test developed AD at a rate of over 12% per year. Thus, it is possible to identify a large cohort of 80-year-olds who are at low risk for AD and a smaller cohort at very high risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712531     DOI: 10.1002/ana.410250402

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  94 in total

1.  Smoking and dementia in male British doctors: prospective study.

Authors:  R Doll; R Peto; J Boreham; I Sutherland
Journal:  BMJ       Date:  2000-04-22

Review 2.  Alzheimer's disease in man and transgenic mice: females at higher risk.

Authors:  R S Turner
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 3.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

4.  The relationship between attention and gait in aging: facts and fallacies.

Authors:  Roee Holtzer; Cuiling Wang; Joe Verghese
Journal:  Motor Control       Date:  2012-01       Impact factor: 1.422

5.  Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects.

Authors:  Nikolaos Scarmeas; Eric Zarahn; Karen E Anderson; John Hilton; Joseph Flynn; Ronald L Van Heertum; Harold A Sackeim; Yaakov Stern
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

6.  High-sensitivity C-reactive protein and mobility disability in older adults.

Authors:  Joe Verghese; Roee Holtzer; Richard B Lipton; Cuiling Wang
Journal:  Age Ageing       Date:  2012-03-14       Impact factor: 10.668

7.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Traumatic brain injury may increase risk of young onset dementia.

Authors:  Raquel C Gardner; Kristine Yaffe
Journal:  Ann Neurol       Date:  2014-03-07       Impact factor: 10.422

9.  Mild Traumatic Brain Injury among the Geriatric Population.

Authors:  Linda Papa; Matthew E Mendes; Carolina F Braga
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-09-01

10.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.